Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Solutions × 1 year × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC) 1

Interventions

Carboplatin 187 pembrolizumab 184 Cisplatin 175 Paclitaxel 156 Gemcitabine 125 Docetaxel 109 Capecitabine 99 Cyclophosphamide 92 Dexamethasone 89 Pemetrexed 87 Doxorubicin 84 Specimen Handling 83 Oxaliplatin 82 Magnetic Resonance Spectroscopy 81 Radiotherapy 78 Fluorouracil 73 Bevacizumab 70 Nivolumab 67 Rituximab 65 Leucovorin 63 Vincristine 60 durvalumab 57 Lenalidomide 57 atezolizumab 53 Radiation 52 Prednisone 52 Etoposide 51 Trastuzumab 49 Irinotecan 49 Drug Therapy 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03903835 2025-04-09

ProBio

Karolinska Institutet

Phase 3 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡